Perioperative management of antiplatelet therapy in patients with cardiovascular disease

Orthopedics

Volumn 31, Issue 12, 2008, Pages 1210-

  Lemon Jr , Stephen J ^a,b   Flynn, Jeremy D ^a   Dunn, Steven P ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CELECOXIB; CILOSTAZOL; CLOPIDOGREL; DICLOFENAC; DIFLUNISAL; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN; WARFARIN;

BARE METAL STENT; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMATOMA; HUMAN; LOADING DRUG DOSE; PERIOPERATIVE PERIOD; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; RETROPERITONEAL HEMATOMA; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STANDARD; STENT THROMBOSIS; STROKE; SURGICAL RISK; THROMBOSIS; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS; GRAFT OCCLUSION; METHODOLOGY;

CARDIOVASCULAR DISEASES; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS;

EID: 63649129447     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20081201-10     Document Type: Review

References (20)

1. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007; 357(24):2482-2494.
2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007; 116(7): e148-304.
3. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006; 48(1):193-202. (Pubitemid 43929240)
4. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 suppl):299S-339S. (Pubitemid 351894915)
5. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007; 49(22):2145-2150. (Pubitemid 46824115)
6. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000; 35(5):1288-1294. (Pubitemid 30206904)
7. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002; 105(10):1257-1267. (Pubitemid 34225832)
8. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003; 42(2):234-240. (Pubitemid 36851411)
9. Awtry EH, Loscalzo J. Aspirin. Circulation. 2000; 101(10):1206-1218.
10. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects; the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 suppl):234S-264S. (Pubitemid 39297956)
11. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006; 119(8):624-638. (Pubitemid 44128438)
12. Mehta SR, Yusuf S. Short-and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol. 2003; 41(4 suppl S):79S-88S. (Pubitemid 36223351)
13. Schühlen H, Hadamitzky M, Walter H, Ulm K, Schömig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial. Circulation.1997; 95(8):2015-2021.
14. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998; 339(23):1665-1671.
15. Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM. Clopidogrel and bleeding after general surgery procedures. Am Surg. 2008; 74(8):721-725.
16. Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy. 2008; 28(3):376-392. (Pubitemid 351337539)
17. Lavelle WF, Demers Lavelle EA, Uhl R. Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus. J Trauma. 2008; 64(4):996-1000.
18. Lenz TL, Hilleman DE. Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Ann Pharmacother. 2000; 34(11):1283-1290. (Pubitemid 30822564)
19. McKenna R. Abnormal coagulation in the postoperative period contributing to excessive bleeding. Med Clin North Am. 2001; 85(5):1277-1310. (Pubitemid 32862143)
20. Scarborough RM. Development of eptifibatide. Am Heart J. 1999; 138(6 pt 1):1093-1104.